1995 Results

People

  1. Kris
    Kris
  2. Motzer
    Motzer
  3. Scher
    Scher
  4. Saltz
    Saltz
  5. Schwartz
    Schwartz
  6. Hudis
    Hudis
  7. Kelsen
    Kelsen
  8. Rosen
    Rosen
  9. Marks
    Marks
  10. De Angelis
    De Angelis

Groups

  1. Department of Medicine (969)
  2. Solid Tumor Oncology Division (729)
  3. Surgery (289)
  4. GSK Faculty (287)
  5. Survivorship Research (260)
  6. Center for Hematologic Malignancies (230)
  7. Sloan Kettering Institute Faculty (227)
  8. Hematologic Malignancies, Division of (224)
  9. Genitourinary Oncology Service (203)
  10. Molecular Pharmacology and Chemistry Program Faculty (172)
  1. "antineoplastic agents"
Formats
  1. Journal Article (1901)
  2. Review (47)
  3. Conference Paper (23)
  4. Editorial (7)
  5. Research Letter (6)
  6. Guidelines (4)
  7. Book Section (3)
  8. Correspondence (2)
  9. Meeting Abstract (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (969)
  2. Solid Tumor Oncology Division (729)
  3. Surgery (289)
  4. GSK Faculty (287)
  5. Survivorship Research (260)
  6. Center for Hematologic Malignancies (230)

More Groups

People
  1. Mark Kris (77)
  2. Robert Motzer (70)
  3. Howard Scher (58)
  4. Gary Schwartz (52)
  5. Leonard Saltz (52)
  6. Ting-Chao Chou (50)

More People

Years
  1. 2025 (16)
  2. 2024 (65)
  3. 2023 (49)
  4. 2022 (49)
  5. 2021 (11)
  6. 2020 (4)

More Years

Publications
  1. Clinical Cancer Research (114)
  2. Journal of Clinical Oncology (111)
  3. Cancer (70)
  4. Seminars in Oncology (51)
  5. New England Journal of Medicine (43)
  6. Cancer Research (40)

More Publications

Publishers
  1. Elsevier Inc. (240)
  2. American Association for Cancer Research (187)
  3. Springer (175)
  4. American Society of Clinical Oncology (129)
  5. Wiley Blackwell (112)
  6. Nature Publishing Group (92)

More Publishers

Results (1995)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • KRAS(G12C) inhibition with sotorasib in advanced solid tumors
    Journal Article

    Hong, D. S.; Fakih, M. G.; Strickler, J. H.; Desai, J.; Durm, G. A.; Shapiro, G. I.; Falchook, G. S.; Price, T. J.; Sacher, A.; Denlinger, C. S.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): A randomised, double-blind, phase 3 trial
    Journal Article

    Mittendorf, E. A.; Zhang, H.; Barrios, C. H.; Saji, S.; Jung, K. H.; Hegg, R.; Koehler, A.; Sohn, J.; Iwata, H.; Telli, M. L.; more...
    Lancet (2020)

    Fulltext@MSK | Save
  • Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): A multicentre, randomised, double-blind, placebo-controlled, phase 3 study
    Journal Article

    Abou-Alfa, G. K.; Macarulla, T.; Javle, M. M.; Kelley, R. K.; Lubner, S. J.; Adeva, J.; Cleary, J. M.; Catenacci, D. V.; Borad, M. J.; Bridgewater, J.; more...
    Lancet Oncology (2020)

    Fulltext@MSK | Save
  • Use of high-cost cancer treatments in academic and nonacademic practice
    Journal Article

    Mitchell, A. P.; Kinlaw, A. C.; Peacock-Hinton, S.; Dusetzina, S. B.; Sanoff, H. K.; Lund, J. L.
    The Oncologist (2020)

    Fulltext@MSK | Save
  • Follicular lymphoma: Recent and emerging therapies, treatment strategies, and remaining unmet needs
    Review

    Matasar, M. J.; Luminari, S.; Barr, P. M.; Barta, S. K.; Danilov, A. V.; Hill, B. T.; Phillips, T. J.; Jerkeman, M.; Magagnoli, M.; Nastoupil, L. J.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML
    Journal Article

    Perl, A. E.; Martinelli, G.; Cortes, J. E.; Neubauer, A.; Berman, E.; Paolini, S.; Montesinos, P.; Baer, M. R.; Larson, R. A.; Ustun, C.; more...
    New England Journal of Medicine (2019)

    Fulltext@MSK | Save
  • Systemic therapy for locally advanced and metastatic non-small cell lung cancer: A review
    Review

    Arbour, K. C.; Riely, G. J.
    JAMA - Journal of the American Medical Association (2019)

    Fulltext@MSK | Save
  • Evaluating the strength of the association between industry payments and prescribing practices in oncology
    Journal Article

    Mitchell, A. P.; Winn, A. N.; Lund, J. L.; Dusetzina, S. B.
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Treatment sequencing for simultaneous colorectal liver metastases
    Review

    Krell, R. W.; D'Angelica, M. I.
    Journal of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer
    Journal Article

    Khorana, A. A.; Soff, G. A.; Kakkar, A. K.; Vadhan-Raj, S.; Riess, H.; Wun, T.; Streiff, M. B.; Garcia, D. A.; Liebman, H. A.; Belani, C. P.; more...
    New England Journal of Medicine (2019)

    Fulltext@MSK | Save